Brussels, 19/01/2007 (Agence Europe) - According to the conclusions of two scientific panels convened by the European Centre for Disease Prevention and Control in Stockholm, there is enough evidence to support a general Pneumococcal Polysaccharide (PPV23) vaccination strategy for people over 65. Although some knowledge gaps remain on this vaccination, the effectiveness of which on the general population appears to be slight, several studies confirm that it enhances the protection of older...